<!DOCTYPE html>
<html lang="en">
 <head>
  <meta charset="utf-8"/>
  <meta content="origin" name="referrer"/>
  <meta content="/images/branding/googleg/1x/googleg_standard_color_128dp.png" itemprop="image"/>
  <title>
   What is Corixa a subsidiary of? - Google Search
  </title>
  <style>
   a{color:#1a0dab;text-decoration:none;-webkit-tap-highlight-color:rgba(0,0,0,.10)}a:visited{color:#4b11a8}a:hover{text-decoration:underline}img{border:0}html{font-family:arial,sans-serif;font-size:14px;line-height:20px;-webkit-text-size-adjust:100%;color:#3c4043;word-wrap:break-word;background-color:#fff}.bz1lBb{background-color:#fff;height:93px;}.KP7LCb{background-color:#fff;padding-left:4px}.BsXmcf{position:absolute;height:1px;left:0;right:0;background-color:#dadce0}.cOl4Id{background-color:#fff}.bRsWnc{overflow:hidden}.N6RWV{height:51px}.Uv67qb{font-size:14px;line-height:20px;font-weight:bold;display:flex}.Uv67qb a,.Uv67qb span{color:#5e5e5e;height:20px;margin:4px 12px 1px;display:block;flex:none;text-align:center;}.OXXup{border-bottom:2px solid #1f1f1f}.Uv67qb .OXXup{font-weight:bold;color:#1f1f1f}a.eZt8xd:visited{color:#5e5e5e}.FElbsf{border-left:1px solid #dadce0}header article{overflow:visible}.Pg70bf{height:39px;display:-webkit-box;display:flex;display:flex;width:100%}.H0PQec{position:relative;flex:1}.Pg70bf{height:26px}.hlm7Y{height:46px;margin-top:26px;border-radius:25px;width:auto;background:#fff;box-shadow:0px 2px 6px rgba(60,64,67,0.16)}.sbc{display:flex}.Pg70bf input{}.x{width:26px;color:#70757a;line-height:40px;margin-top:3px;font:27px/38px arial, sans-serif}#qdClwb{flex:0 0 auto;padding:0;height:33px;margin-top:5px;border-top-right-radius:25px;border-bottom-right-radius:25px;width:48px;background:#fff;border:0;border-left:1px solid #dadce0;background-image:url('data:image/svg+xml,\00003csvg height="37px" width="37px" xmlns="http://www.w3.org/2000/svg">\00003cg fill="none" stroke="%234285F4">\00003cellipse cx="16.5" cy="16" rx="5.4" ry="5.4" stroke-width="2px">\00003c/ellipse>\00003cpath d="M22 21.3l4.3 4.3" stroke-linecap="round" stroke-width="2px">\00003c/path>\00003c/g>\00003c/svg>');}.sc{font-size:16px;position:absolute;top:48px;left:0;right:0;box-shadow:0 2px 5px rgba(0,0,0,.2);z-index:2;background-color:#fff}.sc>div{padding:10px 20px}.scs{background-color:#fafafa;}.noHIxc{display:block;font-size:16px;padding:0 0 0 8px;flex:1;height:35px;outline:none;border:none;width:100%;-webkit-tap-highlight-color:rgba(0,0,0,0);overflow:hidden;padding:4px 0 0 20px}.sbc input[type=text]{background:none}html{background-color:#fff;}body{padding:0;}body{margin:0 auto 0 156px;max-width:652px;min-width:652px;padding:0 8px}.cOl4Id{text-align:center;padding:32px 28px 0 24px;position:absolute;left:0;top:0}footer{text-align:center;margin-top:18px}footer a,footer a:visited,.smiUbb{color:#70757a}.xeDNfc{margin:0 13px;display:inline-block}#EOlPnc{margin-top:36px}#EOlPnc>div{margin:20px}.Srfpq{color:#70757a}
  </style>
 </head>
 <body jsmodel="hspDDf ">
  <header id="hdr">
   <div class="cOl4Id">
    <a href="/?sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQOwgC">
     <svg aria-label="Google" fill="none" height="36" stroke="#4285f4" stroke-width="18" viewbox="0 0 520 174" width="92">
      <path d="M69 70.4l61 0m-9 3.5a56 57 0 1 1-17-47" stroke-width="19px">
      </path>
      <ellipse cx="179" cy="90" rx="33" ry="34" stroke="#ea4335">
      </ellipse>
      <ellipse cx="270" cy="90" rx="33" ry="34" stroke="#fbbc04">
      </ellipse>
      <ellipse cx="358" cy="90" rx="32" ry="34" stroke-width="17px">
      </ellipse>
      <path d="M391 49l0 73l-2 0a 22 22-30 0 1-59 24">
      </path>
      <path d="M423 5l0 130" style="stroke:#34a853">
      </path>
      <path d="M509 110a32 35-3 1 1 3-29M517 76l-63 24" stroke="#ea4335" stroke-width="16px">
      </path>
     </svg>
    </a>
   </div>
   <div class="bz1lBb">
    <form class="Pg70bf hlm7Y" id="sf">
     <input name="num" type="hidden" value="100"/>
     <input name="lr" type="hidden" value="lang_en"/>
     <input name="sca_esv" type="hidden" value="1a233ca9bb5af21c"/>
     <input name="hl" type="hidden" value="en"/>
     <input name="gbv" type="hidden" value="1"/>
     <input name="gl" type="hidden" value="us"/>
     <input name="tbs" type="hidden" value="lr:lang_1en"/>
     <div class="H0PQec">
      <div class="sbc esbc">
       <input autocapitalize="none" autocomplete="off" class="noHIxc" name="q" spellcheck="false" type="text" value="What is Corixa a subsidiary of?"/>
       <input name="oq" type="hidden"/>
       <input name="aqs" type="hidden"/>
       <div class="sc">
       </div>
      </div>
     </div>
     <button id="qdClwb" type="submit">
     </button>
    </form>
   </div>
  </header>
  <div id="main">
   <div>
    <div class="KP7LCb">
     <div class="bRsWnc">
      <div class="N6RWV">
       <div class="Pg70bf Uv67qb">
        <span class="OXXup">
         All
        </span>
        <a class="eZt8xd" href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=isch&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ_AUIBigB">
         Images
        </a>
        <a class="eZt8xd" href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=vid&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ_AUIBygC">
         Videos
        </a>
        <a class="eZt8xd" href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=nws&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ_AUICCgD">
         News
        </a>
        <a href="/url?q=https://maps.google.com/maps%3Fhl%3Den%26q%3DWhat%2Bis%2BCorixa%2Ba%2Bsubsidiary%2Bof%253F%26iflsig%3DAL9hbdgAAAAAZpcEKXXIBTyPFuMGAByodjXr-VnscjVY%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26um%3D1%26ie%3DUTF-8%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQiaAMCAkoBA&amp;usg=AOvVaw2mld0F0qbgb8DRMN2PIReB">
         Maps
        </a>
        <a href="/url?q=/search%3Fq%3DWhat%2Bis%2BCorixa%2Ba%2Bsubsidiary%2Bof%253F%26num%3D100%26lr%3Dlang_en%26sca_esv%3D1a233ca9bb5af21c%26hl%3Den%26gbv%3D1%26gl%3Dus%26tbs%3Dlr:lang_1en%26tbm%3Dshop%26source%3Dlnms%26ved%3D1t:200713%26ictx%3D111&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQiaAMCAooBQ&amp;usg=AOvVaw3phe0WRlGlE89S0aJpF04Z">
         Shopping
        </a>
        <a href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;tbm=bks&amp;source=lnms&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ_AUICygG">
         Books
        </a>
        <div class="FElbsf">
         <a href="/advanced_search" id="st-toggle" role="button" style="white-space:nowrap">
          Search tools
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
    <div class="Pg70bf wEsjbd Gx5Zad xpd EtOod pkphOe" id="st-card">
     <style>
      .wEsjbd{height:44px;white-space:nowrap}.coPU8c{height:60px;-webkit-overflow-scrolling:touch;overflow-x:auto;overflow-y:hidden}.Xj2aue{height:44px;overflow:hidden}.RnNGze{margin:11px 16px}.wEsjbd div,.wEsjbd a,.wEsjbd li{outline-width:0;outline:none}
     </style>
     <div class="Xj2aue">
      <div class="coPU8c">
       <div class="RnNGze">
        <style>
         .PA9J5{display:inline-block}.RXaOfd,.tbcPJb{display:inline-block;height:22px;position:relative;padding-top:0;padding-bottom:0;padding-right:16px;padding-left:0;line-height:22px;cursor:pointer;text-transform:uppercase;font-size:12px;color:#70757a}.sa1toc{background:#fff;display:none;position:absolute;border:1px solid #dadce0;box-shadow:0 2px 4px rgba(0,0,0,.3);margin:0;white-space:nowrap;z-index:103;line-height:17px;padding-top:5px;padding-bottom:5px;padding-left:0}.PA9J5:hover .sa1toc{display:block}.mGSy8d a:active,.RXaOfd:active{color:#4285f4}
        </style>
        <div class="PA9J5">
         <div class="RXaOfd vQYuGf" role="button" tabindex="0">
          <style>
           .TWMOUc{display:inline-block;padding-right:14px;white-space:nowrap}.vQYuGf{font-weight:bold}.OmTIzf{border-color:#909090 transparent;border-style:solid;border-width:4px 4px 0 4px;width:0;height:0;margin-left:-10px;top:50%;margin-top:-2px;position:absolute}.RXaOfd:active .OmTIzf{border-color:#4285f4 transparent}
          </style>
          <div class="TWMOUc">
           Search English pages
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <style>
           .ozatM{font-size:12px;text-transform:uppercase}.ozatM .yNFsl,.ozatM li{list-style-type:none;list-style-position:outside;list-style-image:none}.yNFsl.SkUj4c,.yNFsl a{color:#70757a;text-decoration:none;padding:6px 44px 6px 14px;line-height:17px;display:block}.SkUj4c{background-image:url(//ssl.gstatic.com/ui/v1/menu/checkmark2.png);background-position:right center;background-repeat:no-repeat}.SkUj4c:active{background-color:#f8f9fa}
          </style>
          <li class="yNFsl">
           <style>
            .tbcPJb a{color:#70757a;text-decoration:none}
           </style>
           <a href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbas=0&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQpwUIDA">
            Any language
           </a>
          </li>
          <li class="yNFsl SkUj4c">
           Search English pages
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           Any time
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           Any time
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:h&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQpwUIDw">
            Past hour
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:d&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQpwUIEA">
            Past 24 hours
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:w&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQpwUIEQ">
            Past week
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:m&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQpwUIEg">
            Past month
           </a>
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en,qdr:y&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQpwUIEw">
            Past year
           </a>
          </li>
         </ul>
        </div>
        <div class="PA9J5">
         <div class="RXaOfd" role="button" tabindex="0">
          <div class="TWMOUc">
           All results
          </div>
          <span class="OmTIzf">
          </span>
         </div>
         <ul class="sa1toc ozatM">
          <li class="yNFsl SkUj4c">
           All results
          </li>
          <li class="yNFsl">
           <a href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=li:1&amp;source=lnt&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQpwUIFQ">
            Verbatim
           </a>
          </li>
         </ul>
        </div>
        <div class="tbcPJb" role="button" tabindex="0">
         <a href="https://www.google.com/search?hl=en&amp;source=hp&amp;q=What+is+Corixa+a+subsidiary+of%3F&amp;btnG=Google+Search&amp;iflsig=AL9hbdgAAAAAZpcEKXXIBTyPFuMGAByodjXr-VnscjVY&amp;gbv=1&amp;gl=us&amp;num=100">
          Clear
         </a>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div class="BsXmcf">
   </div>
   <style>
    .Gx5Zad{margin-bottom:30px;margin:0px 0px 8px;}.pkphOe{font-size:14px;line-height:22px;}.EtOod>*:first-child{border-top-left-radius:8px;border-top-right-radius:8px}.EtOod>*:last-child{border-bottom-left-radius:8px;border-bottom-right-radius:8px}.EtOod.avPKgf>*:last-child{border-bottom-left-radius:4px}.fP1Qef{background:transparent !important;box-shadow:none !important;border:none !important}.rl7ilb{display:block;clear:both}.egMi0{margin-bottom:-23px}.kCrYT{padding:16px 14px 12px}a.fdYsqf{color:#4b11a8}.sCuL3{position:absolute;width:100%;top:0;left:0;padding-top:1px;margin-bottom:-1px}.j039Wc{padding-top:28px;margin-bottom:-1px}.DnJfK{position:relative}.l97dzf{font-weight:400}.zBAuLc{line-height:normal;margin:0;padding:0}.BNeawe{white-space:pre-line;word-wrap:break-word}.vvjwJb{color:#1a0dab;font-size:20px;line-height:26px}a:visited .vvjwJb,.vvjwJb a:visited{color:#4b11a8}.vvjwJb.HrGdeb{color:#fff}a:visited .vvjwJb.HrGdeb,.vvjwJb.HrGdeb a:visited{color:rgba(255,255,255,.70)}.UwRFLe{display:-webkit-box;-webkit-box-orient:vertical;overflow:hidden}.UPmit{font-size:14px;line-height:22px}.UPmit.HrGdeb{color:rgba(255,255,255,.70)}.UPmit.AP7Wnd{color:#202124}.lRVwie{text-overflow:ellipsis;white-space:nowrap;overflow:hidden}.Ap5OSd{padding-bottom:12px}.s3v9rd{font-size:14px;line-height:22px}.s3v9rd.HrGdeb{color:#fff}.s3v9rd.AP7Wnd{color:#202124}.mSx1Ee{padding-left:48px;margin:0}.v9i61e{padding-bottom:8px}.K8tyEc{padding-bottom:12px}.mEUgP{font-size:20px;font-weight:bold;line-height:26px;color:#1f1f1f;height:14px;padding:16px 14px 0px 14px;margin:0}.FCUp0c{font-weight:bold}.nRlVm .FCUp0c{background-color:#d3e3fd;color:#040c28}.C7GS5b{margin-left:12px;display:table-cell;vertical-align:middle}.rkGIWe{padding:14px}.rxk4ae{padding-top:6px;padding-bottom:6px}.yStFkb .xpd{box-shadow:none;border-radius:16px;background-color:#f7f8f9;}.oTWEpb{padding-top:16px}.n1Qedd{overflow:hidden;text-align:center}.KMAGC{margin:0 auto;display:block}.ho0sdc{margin:0 -50%;display:inline-block}.PqksIc{font-size:16px;line-height:20px}.x54gtf{height:1px;background-color:#dadce0;margin:0 14px}.Q0HXG{height:1px;background-color:#dadce0;}.Xb5VRe{color:#1a0dab}a:visited .Xb5VRe{color:#4b11a8}.Xb5VRe.tr0dw{color:#fff}a:visited .Xb5VRe.tr0dw{color:rgba(255,255,255,.70)}.P1NWSe{display:table;width:100%;padding-top:16px;padding-bottom:16px;margin-bottom:-12px}.wOMIed{display:table-cell;vertical-align:top}.nkPlDb{vertical-align:middle}.JhFlyf{color:#3c4043;font-size:14px;text-align:center}.VQFmSd{display:block;white-space:pre-line;word-wrap:break-word}.JhFlyf.VQFmSd{line-height:22px}.f4J0H{padding:18px}.r0bn4c.tr0dw{color:rgba(255,255,255,.70)}.r0bn4c.rQMQod{color:#70757a}.cAuxJf{font-size:20px;font-weight:bold;line-height:26px;color:#1f1f1f;margin:0}.tAd8D{font-size:14px;line-height:20px}.tAd8D.HrGdeb{color:rgba(255,255,255,.70)}.tAd8D.AP7Wnd{color:#70757a}.Xdlr0d{overflow-x:auto;-webkit-overflow-scrolling:touch;margin:0 -8px;padding:2px 0 16px 22px;margin-top:-2px;transform:translate3d(0,0,0)}.idg8be{display:table;border-collapse:separate;border-spacing:8px 0;margin:0 -8px;padding-right:14px}.BVG0Nb{display:table-cell;vertical-align:top;overflow:hidden;}.pijXPc{overflow:hidden;border-radius:16px;background-color:#f7f8f9;font-size:18px}.OxTOff{overflow:hidden;border-radius:8px;background-color:#f7f8f9}.WddBJd{display:block;margin:0 auto;border-radius:8px}.RJI4s{vertical-align:middle}.mHhylf{display:table-cell;vertical-align:middle}.WZ5GJf{align-items:center;padding:0 20px;min-width:112px}.qN9Ked,.DXk5Me{margin:0 auto;color:#001d35}.DXk5Me{cursor:pointer;margin-bottom:12px}.Dk7jOe{display:block;margin:0 auto}.Qi9Fd{border:0;border-radius:999px;display:block;height:56px;justify-content:center;width:56px;z-index:0;background:#f7f8f9;}.Qi9Fd:focus{outline:none}.Qi9Fd .hWHuJ{display:block;margin:0 auto}.ji5jpf{text-align:center}.rLshyf,.BmP5tf{padding-top:16px;padding-bottom:12px}.YOx3Ab{padding-left:14px;}.w1C3Le,.BmP5tf,.G5NbBd,.CS4w5b{padding-left:14px;padding-right:14px;}.G5NbBd{padding-bottom:12px}.CS4w5b{padding-top:12px}.nMymef{display:flex}.G5eFlf{flex:1;display:block}.nMymef span{text-align:center}.EYqSq{margin:6px 4px 9px 0;border-radius:100%;display:inline-block;height:10px;vertical-align:middle;width:10px}.dfB0uf{color:#3c4043;font-weight:bold}.IffyKc{word-wrap:break-word}
   </style>
   <div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGQQAg" href="/url?q=https://www.sec.gov/Archives/edgar/data/1042561/000089102003001957/v91776e8vkza.htm&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGQQAg&amp;usg=AOvVaw0aDn7UfHByRb5XAGvqZBlN">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa Corporation Form 8-K/A - SEC.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           On April 4, 2003, Corixa Corporation's subsidiary, Coulter Pharmaceutical, Inc., or Coulter, entered into a sublease agreement with Gryphon Therapeutics, Inc., ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad xpd EtOod pkphOe">
     <div class="K8tyEc">
      <div class="mEUgP">
       <span>
        <div class="BNeawe">
         <span class="FCUp0c rQMQod">
          People also ask
         </span>
        </div>
       </span>
      </div>
     </div>
     <div>
      <span class="C7GS5b rkGIWe rxk4ae">
       <div class="BNeawe s3v9rd AP7Wnd">
        What is the subsidiary of the parent company?
       </div>
      </span>
      <div class="kCrYT" style="padding-bottom:12px;padding-top:0px">
       <div class="yStFkb">
        <div class="Gx5Zad xpd EtOod pkphOe">
         <div class="kCrYT">
          <div class="PqksIc nRlVm">
           <div class="BNeawe">
            <div>
             <div class="BNeawe">
              Key Takeaways. A subsidiary is
              <span class="FCUp0c rQMQod">
               a company that is more than 50% owned by a parent company or holding company
              </span>
              . Subsidiaries are separate and distinct legal entities from their parent companies.
             </div>
            </div>
           </div>
          </div>
         </div>
         <div class="x54gtf">
         </div>
         <div class="kCrYT">
          <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAAQBg" href="/url?q=https://www.investopedia.com/terms/s/subsidiary.asp&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAAQBg&amp;usg=AOvVaw1L2QJW38C4rWb5ngJHzIYL">
           <span>
            <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             <span class="rQMQod Xb5VRe">
              Subsidiary Company: Definition, Examples, Pros &amp; Cons
             </span>
            </div>
           </span>
           <span>
            <div class="BNeawe UPmit AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             www.investopedia.com › terms › subsidiary
            </div>
           </span>
          </a>
         </div>
        </div>
       </div>
       <div>
        <div class="P1NWSe">
         <div class="wOMIed nkPlDb">
          <span class="JhFlyf VQFmSd">
           <a class="f4J0H" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQzmd6BAgAEAc" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=GfaWZumpMIeKwbkPmaWj4AI&amp;q=What+is+the+subsidiary+of+the+parent+company?&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQzmd6BAgAEAc">
            More results
           </a>
          </span>
         </div>
        </div>
       </div>
      </div>
     </div>
     <div class="x54gtf">
     </div>
     <div>
      <span class="C7GS5b rkGIWe rxk4ae">
       <div class="BNeawe s3v9rd AP7Wnd">
        What is a subsidiary of a subsidiary called?
       </div>
      </span>
      <div class="kCrYT" style="padding-bottom:12px;padding-top:0px">
       <div class="yStFkb">
        <div class="Gx5Zad xpd EtOod pkphOe">
         <div class="kCrYT">
          <div class="PqksIc nRlVm">
           <div class="BNeawe">
            <div>
             <div class="BNeawe">
              A
              <span class="FCUp0c rQMQod">
               first-tier subsidiary
              </span>
              means a subsidiary/child company of the ultimate parent company, while a second-tier subsidiary is a subsidiary of a first-tier subsidiary: a "grandchild" of the main parent company.
             </div>
            </div>
           </div>
          </div>
         </div>
         <div class="x54gtf">
         </div>
         <div class="kCrYT">
          <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAAQDQ" href="/url?q=https://en.wikipedia.org/wiki/Subsidiary&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAAQDQ&amp;usg=AOvVaw0uTB25bBxA4cjrHjfomSd4">
           <span>
            <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             <span class="rQMQod Xb5VRe">
              Subsidiary - Wikipedia
             </span>
            </div>
           </span>
           <span>
            <div class="BNeawe UPmit AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
             en.wikipedia.org › wiki › Subsidiary
            </div>
           </span>
          </a>
         </div>
        </div>
       </div>
       <div>
        <div class="P1NWSe">
         <div class="wOMIed nkPlDb">
          <span class="JhFlyf VQFmSd">
           <a class="f4J0H" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQzmd6BAgAEA4" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=GfaWZumpMIeKwbkPmaWj4AI&amp;q=What+is+a+subsidiary+of+a+subsidiary+called?&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQzmd6BAgAEA4">
            More results
           </a>
          </span>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGEQAg" href="/url?q=https://www.patentguru.com/assignee/coulter-pharmaceutical-inc-a-wholly-owned-subsidiary-of-corixa-corporation&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGEQAg&amp;usg=AOvVaw1xuSMxzFfh8v_RYAk5KpgT">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Coulter pharmaceutical inc a wholly owned subsidiary of corixa ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.patentguru.com › assignee › coulter-pharmaceutical-inc-a-wholly-ow...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Abstract: The present invention provides analogues of duocarmycins that are potent cytotoxins. Also provided are peptidyl and disulfide linkers that are cleaved ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGAQAg" href="/url?q=https://www.sec.gov/Archives/edgar/data/1042561/000090342305000559/corixas-8pos52968.htm&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGAQAg&amp;usg=AOvVaw1DdLvRmyDLFhiOPuoES6Ky">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa Corporation - SEC.gov
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.sec.gov › Archives › edgar › data › corixas-8pos52968
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           333-52968) filed by Corixa Corporation (“Corixa”) with the Securities and Exchange Commission (the “Commission”) on December 29, 2000 (the “Registration ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECF4QAg" href="/url?q=https://www.gsk.com/media/7475/gsk-group-company-names-and-addresses.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECF4QAg&amp;usg=AOvVaw1yI0aDvWV2-9xu-0ffcLFj">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Group companies - GSK
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.gsk.com › media › gsk-group-company-names-and-addresses
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           (ix) GSK GP 1 Limited is a subsidiary undertaking of GSK plc and Berkeley Square Pension Trustee Company Limited and is the general partner of GSK (No.1) ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFoQAg" href="/url?q=https://contracts.justia.com/companies/corixa-corp-64843/contract/1228910/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFoQAg&amp;usg=AOvVaw2X6404KZRKShzOslBdcJw9">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           information concerning possible or assumed future results of ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          contracts.justia.com › companies › corixa-corp-64843 › contract
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... CORIXA CORP filed with the Securities and Exchange Commission ... subsidiary of Corixa ("Coulter"), (Corixa and Coulter being hereinafter collectively and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGMQAg" href="/url?q=https://www.pharmaceuticalonline.com/doc/corixa-and-coulter-merge-0001&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGMQAg&amp;usg=AOvVaw20SBMJriW6Zn8Q_iXj8I-d">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa and Coulter merge - Pharmaceutical Online
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.pharmaceuticalonline.com › doc › corixa-and-coulter-merge-0001
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Forming new company based on immunotherapy. Research-based biotech Corixa Corp. (Seattle) and Coulter Pharmaceutical (San Francisco) have merged following ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECF8QAg" href="/url?q=https://www.gsk.com/media/3611/gsk-group-company-names-and-addresses.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECF8QAg&amp;usg=AOvVaw0QkIPVEcFf8qgHvek8N54M">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] gsk-group-company-names-and-addresses.pdf
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.gsk.com › media › gsk-group-company-names-and-addresses
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa Corporation. Common. Corporation Service Company, 251 Little Falls Drive, Wilmington,
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECF0QAg" href="/url?q=https://www.bioworld.com/articles/522219-corixa-in-licenses-optivax-delivery-system-for-vaccines&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECF0QAg&amp;usg=AOvVaw2AX-dRpE4sEtD_mU6bIcMO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa in-licenses Optivax delivery system for vaccines - BioWorld
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bioworld.com › articles › 522219-corixa-in-licenses-optivax-delivery...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 12, 1996
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The CytRx subsidiary Vaxcel has signed a licensing agreement with Corixa for the use of its vaccine delivery and adjuvant system, Optivax(R) ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFsQAg" href="/url?q=https://www.seattlepi.com/business/article/Tech-Briefs-1083152.php&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFsQAg&amp;usg=AOvVaw1psDaZM75fiJmSbrjZoEAt">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Tech Briefs - Seattle PI
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.seattlepi.com › Business
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 18, 2002
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Under terms of the agreement, Corixa will provide exclusive rights to Ortho-Clinical Diagnostics, allowing the Raritan, N.J., company to use ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFwQAg" href="/url?q=https://www.biospace.com/article/releases/glaxosmithkline-acquires-influenza-vaccine-manufacturer-id-biomedical-/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFwQAg&amp;usg=AOvVaw3Nc8DMsNRWXaosNY3czRQ6">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GlaxoSmithKline Acquires Influenza Vaccine Manufacturer ID ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.biospace.com › article › releases › glaxosmithkline-acquires-influenz...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 8, 2005
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ID Biomedical becomes a wholly-owned subsidiary of GSK. ... acquisition of Corixa Corporation and the purchase of the Marietta, PA vaccine site.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECE8QAg" href="/url?q=https://wireless2.fcc.gov/UlsEntry/attachments/attachmentView.jsp%3FapplType%3Dsearch%26fileKey%3D1556279394%26attachmentKey%3D18474789%26attachmentInd%3DapplAttach&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECE8QAg&amp;usg=AOvVaw2QwOFLjepnPCUD2Hk03nBi">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Untitled - Federal Communications Commission
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          wireless2.fcc.gov › UlsEntry › attachments › attachmentView
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ("WAL" or. “Assignor”) to Corixa Corporation d/b/a GlaxoSmithKline Biologicals North America ... indirect wholly-owned subsidiary of GlaxoSmithKline plc (“ ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFkQAg" href="/url?q=https://contracts.justia.com/companies/corixa-corp-64843/contract/1214553/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFkQAg&amp;usg=AOvVaw3-Uqm7PM6gJuGRCTY2ezdX">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Legal Proceedings | CORIXA CORP | Business Contracts | Justia
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          contracts.justia.com › companies › corixa-corp-64843 › contract
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... CORIXA CORPORATION AND INPHARZAM INTERNATIONAL, S.A., A WHOLLY OWNED SUBSIDIARY OF ZAMBON GROUP SPA, AS AMENDED (THE "AGREEMENT") Dear Dr. Rettani: This ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFgQAg" href="/url?q=https://www.bioprocessonline.com/doc/incyte-and-corixa-enter-into-genomic-partners-0001&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFgQAg&amp;usg=AOvVaw0V91KvOHmFl0j38i57EMFZ">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Incyte and Corixa Enter into Genomic Partnership for Vaccine ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bioprocessonline.com › doc › incyte-and-corixa-enter-into-genomic-...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 23, 2000
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           (Seattle), a research- and development-based biotechnology company, announced today an agreement in which Corixa will gain access to Incyte's ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFYQAg" href="/url?q=https://www.bioworld.com/articles/549187-corixa-receives-milestone-from-organon-for-ra-collaboration&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFYQAg&amp;usg=AOvVaw1WiXru6hZy7aq0sQru---U">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa receives milestone from Organon for RA ... - | BioWorld
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bioworld.com › articles › 549187-corixa-receives-milestone-from-or...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Under a worldwide partnership with Organon, a subsidiary of Akzo Nobel, Corixa has received a milestone payment triggered by completion of a randomized ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFcQAg" href="/url?q=https://proniras.com/steven-gillis-phd/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFcQAg&amp;usg=AOvVaw0cItPf0SQhaB5knDx5WDkA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Steven Gillis, PhD - Proniras
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          proniras.com › steven-gillis-phd
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Dr. Gillis was a founder and director of Corixa Corporation and served as the company's Chief Executive Officer since inception and as its chairman since ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFUQAg" href="/url?q=https://www.ibisworld.com/us/company/glaxosmithkline-plc/10414/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFUQAg&amp;usg=AOvVaw2fm9rgMH1CuXyBZmCODIGr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Glaxosmithkline Plc - Company Profile Report - IBISWorld
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ibisworld.com › company › glaxosmithkline-plc
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Brands. Block Drug Copmany Inc, Corixa Corporation, GlaxoSmithKline, GlaxoSmithKline Capital Inc, GlaxoSmithKline Consumer Healthcare Holdings LLC ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFQQAg" href="/url?q=https://www.biocentury.com/article/120151/corixa-idec-glaxosmithkline-cancer-news&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFQQAg&amp;usg=AOvVaw3fkWqBnoXfLQMN2cfWFCIL">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa, Idec, GlaxoSmithKline cancer news - BioCentury
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.biocentury.com › article › corixa-idec-glaxosmithkline-cancer-news
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           subsidiary and the University of Michigan, seeks a declaration that Zevalin does not infringe CRXA's radioimmunotherapy patents. The second, filed against ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFIQAg" href="/url?q=https://www.crunchbase.com/acquisition/glaxosmithkline-acquires-corixa-corp--d582bf80&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFIQAg&amp;usg=AOvVaw08Rs3g0ev9sOpSYwjzbr9T">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GlaxoSmithKline acquires Corixa - 2005-05-02 - Crunchbase
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.crunchbase.com › acquisition › glaxosmithkline-acquires-corixa-corp...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           GlaxoSmithKline GlaxoSmithKline develops and markets products in the areas of pain relief, respiratory, digestive health, oral health, nutrition and skin.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFMQAg" href="/url?q=https://www.bizjournals.com/seattle/stories/1999/11/01/daily14.html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFMQAg&amp;usg=AOvVaw1UPmdp1Lj1G1BHikY96IhM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa vaccine gets Canada OK - Puget Sound Business Journal
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bizjournals.com › seattle › stories › 1999/11/01 › daily14
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa Corp. of Seattle said Canada's Health Protection Branch has approved the company's melanoma therapeutic vaccine for sale.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFEQAg" href="/url?q=http://test.pharmabiz.com/news/corixa-and-genesis-research-discontinue-pvac-treatment-programme-19515&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFEQAg&amp;usg=AOvVaw1B4HEvT9Om27VcAR7vPzR1">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa and Genesis Research discontinue PVAC treatment ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          test.pharmabiz.com › news › corixa-and-genesis-research-discontinue-pvac...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa and Genesis Research discontinue PVAC treatment programme. ... AgriGenesis Biosciences Ltd is a wholly owned subsidiary of Genesis that is ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECE4QAg" href="/url?q=https://www.bioprocessonline.com/doc/corixa-corp-licenses-wilms-tumor-gene-from-mi-0001&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECE4QAg&amp;usg=AOvVaw2_zxBfcYWKHC6HhiCkPmf_">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa Corp. Licenses Wilm's Tumor Gene From MIT
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bioprocessonline.com › doc › corixa-corp-licenses-wilms-tumor-gene...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 8, 1999
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Corixa Corp. has acquired an exclusive ... OB) (www.generex.com) announced today that its wholly-owned subsidiary, Antigen Express, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFAQAg" href="/url?q=http://getfilings.com/o0000950124-05-001574.html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECFAQAg&amp;usg=AOvVaw0PSx3GxMnIe_wh0QuXTEX4">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           CORIXA CORP - 10-K Annual Report - 12/31/2004
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          getfilings.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Aventis. In March 2004, we entered into license and supply agreements with Aventis Pasteur, or Aventis, under which we granted Aventis co-exclusive and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDUQAg" href="/url?q=https://www.carricktherapeutics.com/investors/corporate-governance/board-of-directors&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDUQAg&amp;usg=AOvVaw2jt_HK6CRXrXMZsimGbL3v">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Board of Directors - Carrick Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.carricktherapeutics.com › investors › corporate-governance › board-...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           GlaxoSmithKline acquired Corixa Corporation in July of 2005. Prior to starting Corixa, Dr. Gillis was a founder and director of Immunex Corporation. From ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECE0QAg" href="/url?q=https://www.nature.com/articles/nbt1200_1230a.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECE0QAg&amp;usg=AOvVaw0nqHZYRdD0iOlY9dj0ef_U">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Research collaborations Monsanto IPOs again Gelsingers, UPenn ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.nature.com › articles
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           cultural subsidiary. AB. Gelsingers, UPenn settle suit. The lawsuit brought by Jesse ... On October 16, Corixa (Seattle, WA) agreed to purchase Coulter ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEsQAg" href="/url?q=https://link.springer.com/content/pdf/10.1007/BF03256966.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEsQAg&amp;usg=AOvVaw1VrwjSob5h-aTJAi-YjkMj">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corporate Activity – Mergers and Acquisitions
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          link.springer.com › content › pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           GSK agreed to acquire Corixa. The acquisition is company with a primary focus on compounds targeting structured as a cash for stock transaction, with the.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEwQAg" href="/url?q=https://www.latimes.com/archives/la-xpm-2005-sep-02-fi-chiron2-story.html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEwQAg&amp;usg=AOvVaw344cMSigtpqDW32RqYQYnY">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Novartis Bids $4.5 Billion for Rest of Chiron - Los Angeles Times
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.latimes.com › archives › la-xpm-2005-sep-02-fi-chiron2-story
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 2, 2005
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The proposed deal comes two months after British drug giant GlaxoSmithKline acquired Corixa Corp., a Seattle biotechnology company, and Shire ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEkQAg" href="/url?q=https://www.genewatch.org/uploads/f03c6d66a9b354535738483c1c3d49e4/JT_Briefing.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEkQAg&amp;usg=AOvVaw0nyao_CTlvUHHUCD4Br34J">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Biotech Deals Put Lung Cancer Vaccine Hopes in the Hands of ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.genewatch.org › uploads › JT_Briefing
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 2, 2001
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Corixa Corporation (www.corixa.com). The Company. Corixa Corporation ... Inc (a wholly owned subsidiary of Japan. Tobacco Inc ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEoQAg" href="/url?q=https://unfairtobacco.org/en/corporations/japan-tobacco-international/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEoQAg&amp;usg=AOvVaw1aeuqX3Lv7WxxEtZBpnU80">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Japan Tobacco International - unfairtobacco
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          unfairtobacco.org › corporations › japan-tobacco-international
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... owned subsidiary of Japan Tobacco Inc. ... In 1999, the corporation acquired exclusive rights to commercialize lung cancer vaccines from the US company Corixa.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEcQAg" href="/url?q=https://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(05)77603-0.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEcQAg&amp;usg=AOvVaw1FmeM7hcEcuEjAvLVw1Fo8">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Kill or cure—confused messages from Japan To b a c c o - The Lancet
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.thelancet.com › pdfs › journals › lancet › PIIS0140-6736(05)77603-0
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           company, Corixa. If the vaccines are approved, Japan Tobacco will find itself in the unusual position of marketing products that cause, prevent, and treat ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEgQAg" href="/url?q=https://ir.nasdaq.com/static-files/a2ed8ac4-cfac-447c-9f35-af333c6e2baf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEgQAg&amp;usg=AOvVaw2IE6cLP8eyXv4yfReqjrDR">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Semi-annual Changes to the NASDAQ Biotechnology Index
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.nasdaq.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa Corporation, headquartered in Seattle, Washington, is a developer of ... Barclays Global Fund. Advisors serves as an advisor to iShares and is a subsidiary ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEQQAg" href="/url?q=https://www.scoop.co.nz/stories/SC0312/S00070.htm&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEQQAg&amp;usg=AOvVaw2Y7WFB7MZHQ71Cb0fsrkTX">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genesis Research Provide Update On PVAC™ Treatment | Scoop ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.scoop.co.nz › stories
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Auckland and Seattle, December 22, 2003 – Genesis Research and Development Corporation Ltd (NZX/ASX: GEN) and Corixa Corporation (Nasdaq: CRXA) today ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEUQAg" href="/url?q=https://www.lawinsider.com/company/1042561/corixa-corp&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEUQAg&amp;usg=AOvVaw1OAGMcgaPwQc_ThjHMwxju">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa Corp Sample Contracts | Law Insider
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.lawinsider.com › company › corixa-corp
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           View Corixa Corp contracts and agreements from SEC filings. Including company executives, business partners, clauses and more.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEYQAg" href="/url?q=https://www.archventure.com/team/steve-gillis/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEYQAg&amp;usg=AOvVaw0Ln1EcrowcMmD9cIK4aDX3">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Steve Gillis, Ph.D. - ARCH Venture Partners
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.archventure.com › team › steve-gillis
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Prior to Corixa, Dr. Gillis was a founder and director of Immunex Corp ... subsidiary. Dr. Gillis was interim CEO of Immunex following its majority ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEMQAg" href="/url?q=https://discovery-patsnap-com.libproxy1.nus.edu.sg/topic/specific-immunotherapy/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEMQAg&amp;usg=AOvVaw0woPMJQNXpJLmgqTk43MkK">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Top 20 Specific immunotherapy companies - Discovery|PatSnap
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          discovery-patsnap-com.libproxy1.nus.edu.sg › topic › specific-immunothe...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEEQAg" href="/url?q=https://discovery.patsnap.com/topic/tuberculosis/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEEQAg&amp;usg=AOvVaw3Q5gTTGN61A-qAlvHD10A-">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Top 20 Tuberculosis companies - Discovery|PatSnap
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          discovery.patsnap.com › topic › tuberculosis
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa was acquired by GlaxoSmithKline on 12 July 2005, and GSK had formerly made use of the Corixa's MPL adjuvant in some of their vaccines. The company ceased ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEIQAg" href="/url?q=http://www.bccancer.bc.ca/research-technology-develoment-office-site/Documents/AdroitScientists3.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEIQAg&amp;usg=AOvVaw0RSLnEs9GKaXkdwQK2nHWB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Adroit Scientists - BC Cancer
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bccancer.bc.ca › Documents › AdroitScientists3
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jan 30, 2001
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Its research sometimes helps Corixa, the for-profit developer of drugs and vaccines Dr. Reed co-founded in 1994. He is now the company's ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEAQAg" href="/url?q=https://permid.org/1-4295906054&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECEAQAg&amp;usg=AOvVaw02K7cBJh0NRJyqtgvYaOY7">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Corixa Corp - PermID
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          permid.org › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa Corp ; PermID. 4295906054 ; Public. No ; Status. Active ; Inactive Date. Login Required ; Latest Date of Incorporation. 07 Sep, 1994.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECD8QAg" href="/url?q=https://hibercell.com/department/board-of-directors/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECD8QAg&amp;usg=AOvVaw0sqNHwrVWKAQ522SwdN-Kx">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Board of Directors Archives - HiberCell
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          hibercell.com › department › board-of-directors
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Prior to Corixa, Dr. Gillis was a founder and director of Immunex Corp., the most successful venture-funded biotech company in the state of Washington. From ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECD0QAg" href="/url?q=https://dpcpsi.nih.gov/sites/default/files/opep/document/Final_Report_%252806-610-OD-OER%2529_10-18-10.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECD0QAg&amp;usg=AOvVaw0x9KjNbT_12arvWnLUhu7f">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Visit the National Academies Press online, the ... - DPCPSI
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          dpcpsi.nih.gov › opep › Final_Report_(06-610-OD-OER)_10-18-10
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Company. Elizabeth Downing. CEO. 3D Technology Laboratories. M. Christina ... Corixa Corporation. 9/15/1994 9/1/2000. 8. 7,971,063. Cortechs Labs, Inc. 5/1 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDwQAg" href="/url?q=https://frazierls.com/portfolio/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDwQAg&amp;usg=AOvVaw2Mlb6Qd1FC9S5js9r7YcJV">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Portfolio - Frazier Life Sciences -
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          frazierls.com › portfolio
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa was a biopharmaceutical company focusing on innovative oncology and immunology-based products. ... In 2019, Semnur merged with Scilex, a majority owned ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECD4QAg" href="/url?q=https://www.bloomberg.com/news/articles/2003-06-29/horizon-organic-rises-on-dean-foods-deal&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECD4QAg&amp;usg=AOvVaw11FnSpFpxxpL5Cd18gfl_t">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Horizon Organic Rises on Dean Foods Deal - Bloomberg
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.bloomberg.com › news › articles › horizon-organic-rises-on-dean-fo...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa (CRXA ) said the FDA approved Bexxar, which was developed by Corixa ... corporation owned by Symphony Technology II-A, L.P. Terms: $3.30 cash per ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDsQAg" href="/url?q=https://investors.biogen.com/static-files/ad6e9e9b-f44b-4b09-b9d2-6913e1be61c9&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDsQAg&amp;usg=AOvVaw2yvKFwArD6aEUSn7Bq3ygc">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.biogen.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Corixa Corporation, or Corixa, Coulter. Pharmaceutical, Inc., or Coulter, and ... Company or any Parent or Subsidiary corporation) first become ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDoQAg" href="/url?q=https://www.vbivaccines.com/our-pipeline/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDoQAg&amp;usg=AOvVaw0STLi4DZUQ3iwmYwYIw-HM">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Our Pipeline - VBI Vaccines
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.vbivaccines.com › our-pipeline
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Dr. Gillis was a founder and director of Corixa Corporation and served as CEO from its inception and as its Chairman from 1999 until its acquisition in 2005 by ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDkQAg" href="/url?q=https://www.umt.edu/law/newsevents/events/ip-day.php&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDkQAg&amp;usg=AOvVaw3EJsKmMM8a0hqxH0ZZPvvb">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           IP Day in Montana
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.umt.edu › law › newsevents › events › ip-day
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           The University of Montana (UM) uses the Collegiate Licensing Company to receive and review the applications and requests for licenses. UM's Chief Licensing ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDgQAg" href="/url?q=https://www.cbinsights.com/company/acylin-pharmaceuticals/people&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDgQAg&amp;usg=AOvVaw2rFevIs58d7hp3GMFFcpfN">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Acylin Therapeutics - CB Insights
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cbinsights.com › company › acylin-pharmaceuticals › people
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           and served as the company's Chief Executive Officer since inception and as its Chairman since January of 1999. Corixa was acquired by GlaxoSmithKline in July of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDcQAg" href="/url?q=https://assets-dam.takeda.com/image/upload/Global/Investor/form20-f/E_FY2023_Form_20-F.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDcQAg&amp;usg=AOvVaw0jsNkHVTaCAXOshSIx5avX">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form 20-F FY2023 - Takeda
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          assets-dam.takeda.com › image › upload › Global › Investor › E_FY2...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 26, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... owned subsidiary of Pfizer Inc. (“Pfizer”), and have commercialization rights ... founder and Director of Corixa Corporation, acquired by.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAQQAg" href="/url?q=https://www.atarabio.com/company/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAQQAg&amp;usg=AOvVaw0eXLRfbVnnUC21oGdJTzQh">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           T-Cell Immunotherapy Technology Platform - Atara Biotherapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.atarabio.com › company
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Jill came to Atara from OncoMed Pharmaceuticals, a wholly owned subsidiary ... Jill also held a similar role at Corixa Corporation (formerly Coulter ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDQQAg" href="/url?q=https://www.uspto.gov/web/offices/ac/ido/oeip/taf/data/topo_03.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDQQAg&amp;usg=AOvVaw0ygFKKEpOuRwYQ1Qh08U3N">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] PATENTING BY ORGANIZATIONS 2003 - USPTO
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.uspto.gov › web › offices › ido › oeip › taf › data › topo_03
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 10, 2004
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           No attempt has been made to combine data based on subsidiary relationships. ... CORIXA CORPORATION. Patents By Year of Grant: 41 41. ENGELHARD ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDYQAg" href="/url?q=https://www.aahi.org/news/aahi-announces-panelist-for-world-vaccine-congress-2024/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDYQAg&amp;usg=AOvVaw3uZQ2SuSfOIfMkrFoqieqD">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           AAHI Announces Panelist for World Vaccine Congress 2024
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.aahi.org › news › aahi-announces-panelist-for-world-vaccine-congres...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Feb 20, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Corixa Corporation) where he held various roles including North American Pre-Clinical Innovation Team Leader, Project Leader, and Investigator.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDIQAg" href="/url?q=https://www.davelerner.com/dave-lerner/david_b_lerner/2009/09/some-examples-of-private-sales-and-ipos-from-columbia-university-startups.html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDIQAg&amp;usg=AOvVaw2gHU0y2GW341ZvRrgeJDXa">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Some Examples of Private Sales and IPO's from Columbia ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.davelerner.com › dave-lerner › david_b_lerner › 2009/09 › some-ex...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Sep 28, 2009
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Corixa (Acquired by GSK for $300 million) ... Corixa is a biotechnology company involved in the identification of novel genes. The company ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDMQAg" href="/url?q=https://www.fiercebiotech.com/biotech/paratek-pharmaceuticals-inc-highlights-newly-expanded-board-of-directors&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDMQAg&amp;usg=AOvVaw3BLNUqnxjCIYys38rG1l2V">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Paratek Pharmaceuticals, Inc. Highlights Newly Expanded Board Of ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.fiercebiotech.com › biotech › paratek-pharmaceuticals-inc-highlights...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 6, 2014
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Mr. Bigham was formerly Vice Chairman of Corixa Corporation, a publicly traded biotechnology company, and was President and Chief Executive of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECC8QAg" href="/url?q=https://www.nutcrackerx.com/about/leadership/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECC8QAg&amp;usg=AOvVaw3BVWSNtbvY5g-akG-SCc5i">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Leadership - Nutcracker Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.nutcrackerx.com › About
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... company, until it merged into Corixa Corporation. Previously, he was an ... Collins served as President of Clinical Micro Sensors, Inc., then a subsidiary of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDEQAg" href="/url?q=https://www.mozart-tx.com/about/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDEQAg&amp;usg=AOvVaw3--INt7CebMDX2Cnoggpbm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Leadership | BOD | SAB | Partners - Mozart Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.mozart-tx.com › about
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Gillis was a Founder and Director of Corixa Corporation and served as the company's ... subsidiary. He was interim Chief Executive Officer of Immunex ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDAQAg" href="/url?q=https://investors.icosavax.com/static-files/618d7371-f13b-4a7f-b550-ad115dff53da&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECDAQAg&amp;usg=AOvVaw03bAHX1hQH2zpw_FUmM12u">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           ICOSAVAX, INC.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.icosavax.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 14, 2021
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Corixa Corporation, a private immunotherapeutics company acquired by ... subsidiary, division, business segment or business unit of the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECC0QAg" href="/url?q=https://ir.celldex.com/node/8871/html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECC0QAg&amp;usg=AOvVaw17GC77CTGq3R2TIqHT-zrI">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing | Celldex Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.celldex.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa Corporation (“Corixa”): In December, 2005, Corixa Corporation, a wholly-owned subsidiary of GlaxoSmithKline, and Celldex Ltd (formerly Lorantis Ltd.) ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECC4QAg" href="/url?q=https://investor.anipharmaceuticals.com/static-files/073de963-0c05-41cd-90c7-19235f44f660&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECC4QAg&amp;usg=AOvVaw3qrAzGRqR8UioJ7i9cFktt">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [RTF] 1. organization - Investor Relations - ANI Pharmaceuticals, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.anipharmaceuticals.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... owned subsidiary of Structured Biologicals. The amalgamation was approved by our ... Competitive or comparable companies to us include Corixa Corporation ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCwQAg" href="/url?q=https://curevovaccine.com/management-team/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCwQAg&amp;usg=AOvVaw0sWnoN8u9YIqxucnCjQ5Qr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Management Team - Curevo Vaccine
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          curevovaccine.com › management-team
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Prior to that Greg was CEO of Clickworker USA, a US subsidiary of a venture backed German Crowdsourcing platform. ... companies, Immune Design Corp and Corixa ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCkQAg" href="/url?q=https://www.vbivaccines.com/investors/press-releases/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCkQAg&amp;usg=AOvVaw0_ZMyXYf8TyoNtgP5pT0Xm">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Press Releases - VBI Vaccines
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.vbivaccines.com › Investors
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Patriarca served, among other positions, as Director of the Division of Viral Products in the Office of Vaccines Research and Review (OVRR), CBER. In that ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCsQAg" href="/url?q=http://www.kblhealthcare.com/portfolio.html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCsQAg&amp;usg=AOvVaw2iLmSJplAp1tmzYNwNHYpL">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Portfolio - KBL Healthcare Ventures
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.kblhealthcare.com › portfolio
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa Corporation, based in Seattle, WA, is a developer of immunotherapeutics with a commitment to treating and preventing autoimmune diseases, cancer and ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCcQAg" href="/url?q=https://hibercell.com/%3Fteam%3Dsteven-gillis-phd&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCcQAg&amp;usg=AOvVaw3Ec42KrfWvzzsbEKA2OXtE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Steven Gillis, Ph.D. - HiberCell
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          hibercell.com › ...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Prior to Corixa, Dr. Gillis was a founder and director of Immunex Corp., the ... subsidiary. Dr. Gillis was interim CEO of Immunex Corp. following its ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCoQAg" href="/url?q=https://www.nature.com/articles/nbt0300_247a.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCoQAg&amp;usg=AOvVaw0PXtz5IiBxk2xJ1XM6fPxr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Human genetics research in Iceland to diversify - Nature
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.nature.com › articles
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa will provide Genset with materials related to the organism, and ... UVS subsidiary in Reykjavik, has announced an umbrella agreement with the.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCYQAg" href="/url?q=https://www.fdanews.com/articles/72000-briefs&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCYQAg&amp;usg=AOvVaw33glevFWSt35_JWbQRq6VY">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Briefs | FDAnews
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.fdanews.com › articles › 72000-briefs
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            May 6, 2005
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           GlaxoSmithKline (GSK) plans to acquire biotechnology firm Corixa for $300 million — a move that will bolster the British drug giant's vaccine ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCgQAg" href="/url?q=https://www.uscis.gov/sites/default/files/document/data/L_FY17_Approved_Petitions_010918.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCgQAg&amp;usg=AOvVaw2dwYA4SHAZegRcoxhZZvwB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Approved L1 Petitions by Employer Fiscal Year 2017 - USCIS
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.uscis.gov › files › data › L_FY17_Approved_Petitions_010918
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... Subsidiary, and Regional Managing Off. 31 Continuing. L1A. D. 432054614 ... CORIXA CORPORATION. Pharmaceutical Preparation Manufacturing. D. Continuing. L1A. D.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCUQAg" href="/url?q=https://oncoresponse.com/about/board-of-directors.php&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCUQAg&amp;usg=AOvVaw0CLs1nIjtWy1lRFZyVHZfd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Board of Directors - About - OncoResponse
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          oncoresponse.com › about › board-of-directors
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           and served as the company's Chief Executive Officer since inception and as its Chairman since January of 1999. Corixa was acquired by GlaxoSmithKline in July of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCIQAg" href="/url?q=https://ir.supernus.com/node/8356/html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCIQAg&amp;usg=AOvVaw2UjAB9FCkfEQrFHyjclfY1">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Supernus Pharmaceuticals
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.supernus.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... subsidiary of Shire plc. From 1999 to 2004, he also served as a member of ... Corixa Corporation, and was President and Chief Executive of Coulter ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCQQAg" href="/url?q=https://sonothera.com/about/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCQQAg&amp;usg=AOvVaw37bcSG0EQcrDzQiOm4V6Al">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Bringing the future of genetic medicine to patients. - SonoThera
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          sonothera.com › about
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           We're a biotechnology company developing ultrasound-guided nonviral gene therapy for diseases with suboptimal or non-existent treatments.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCMQAg" href="/url?q=https://www.annualreports.com/HostedData/AnnualReportArchive/g/LSE_GSK_2005.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCMQAg&amp;usg=AOvVaw3N8Bol90ew-XzqMjhhcpTO">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] GSK Annual Report 2005 - AnnualReports.com
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.annualreports.com › AnnualReportArchive › LSE_GSK_2005
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 1, 2006
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           The acquisition of Corixa gives us valuable adjuvant technology ... subsidiary and associated undertakings constitute a major global ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCAQAg" href="/url?q=https://www.treatmentactiongroup.org/wp-content/uploads/2019/12/pipeline_tb_vaccines_2019_mf_final.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCAQAg&amp;usg=AOvVaw2M1Ft6mFmgIC87Zjsa8Fdj">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Pipeline Report » 2019 - Treatment Action Group
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.treatmentactiongroup.org › pipeline_tb_vaccines_2019_mf_final
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Oct 12, 2019
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           MPL: The MPL used in AS01E originated at Corixa Corp., a small biotech company ... owned subsidiary of Agenus Inc., a Delaware, USA corporation.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECB0QAg" href="/url?q=https://www.cbinsights.com/company/genesis-research-development/people&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECB0QAg&amp;usg=AOvVaw0MtYn4Pg-tNuWIMRXm4rp9">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Genesis Research &amp; Development - CB Insights
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.cbinsights.com › company › genesis-research-development › people
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Gillis was a founder and director of Corixa Corp. and served as the company's Chief Executive Officer since inception and as its Chairman since January of 1999.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCEQAg" href="/url?q=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2622829/pdf/15298231.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECCEQAg&amp;usg=AOvVaw28rGtFVqRS1p9adGp8Tccl">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Ailing Russian health-care system in urgent need of reform - NCBI
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ncbi.nlm.nih.gov › pmc › articles › PMC2622829 › pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Belgian subsidiary, Tibotec Pharmaceu- ticals, has since been developed ... Institute and biotech company Corixa are working on the project with TDR ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECB8QAg" href="/url?q=https://www.jaad.org/article/S0190-9622(04)02784-7/pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECB8QAg&amp;usg=AOvVaw2e-AWb0Z97FAtaZOasZL6c">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           POSTER DISCUSSION SESSION 491—PSORIASIS
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.jaad.org › article › pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Connetics Corporation, Corixa Corporation, Dermik Laboratories, Doak ... Koo is an employee of Amgen. Writing support and poster production provided by Immunex ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBwQAg" href="/url?q=https://discovery-patsnap-com.libproxy.mit.edu/company/unitech-pharmaceuticals/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBwQAg&amp;usg=AOvVaw30i_9-Ec46lENCzZ70qb0V">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Unitech Pharmaceuticals, Inc. - Discovery
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          discovery-patsnap-com.libproxy.mit.edu › Autoimmune disease
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Unitech Pharmaceuticals, Inc. · Basic Info · Related Topics · Data Snapshot · High Related Markets · Subsidiary Lists · Unitech Pharmaceuticals, Inc. Frequently Asked ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECB4QAg" href="/url?q=https://www.ded.uscourts.gov/sites/ded/files/opinions/02-104.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECB4QAg&amp;usg=AOvVaw0vp62SaaCdsmFgLI3fVVkt">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 1 Some of the actions giving rise to the plaintiffs' claims were taken ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ded.uscourts.gov › sites › ded › files › opinions
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Pekan, a subsidiary of Unicredito, is a Polish bank that also has its ... See Corixa Corp. v. IDEC Pharms. Corp., No. CIV.A. 01-615-GMS, 2002 WL 265094 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBsQAg" href="/url?q=http://media.corporate-ir.net/media_files/IROL/25/253770/pdf/PRTK%2520Mgt%2520Announcement%252007.01.14.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBsQAg&amp;usg=AOvVaw36v_wuDXHZe_INSP_Zr7Y1">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Paratek appoints Michael Bigham as Chairman and CEO
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          media.corporate-ir.net › media_files › IROL › pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Michael was formerly Vice Chairman of Corixa Corporation, a publicly-‐traded biotechnology company, and was President and Chief Executive of Coulter.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBoQAg" href="/url?q=https://assets-dam.takeda.com/image/upload/v1687949092/Global/Investor/form20-f/E_FY2022_Form_20-F.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBoQAg&amp;usg=AOvVaw0yAuzJcvS-24J1ZrQDPG9B">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Form 20-F FY2022 - Takeda Pharmaceuticals
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          assets-dam.takeda.com › image › upload › Global › Investor › E_FY2...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 28, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Director of Corixa Corporation, acquired by GlaxoSmithKline in 2005 ... owned subsidiary of Nimbus. The transaction closed in February ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBkQAg" href="/url?q=https://www.lawinsider.com/clause/by-corixa&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBkQAg&amp;usg=AOvVaw00P-JGjTVX2IvgqYQjJYBP">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           By Corixa Sample Clauses - Law Insider
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.lawinsider.com › clause › by-corixa
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           By Corixa. Corixa warrants and represents to Introgen that: (a) it has ... By Company The Company may terminate the Executive's employment under this ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBcQAg" href="/url?q=https://www.iowaregents.edu/media/cms/0906-item07b-pdf07F620F4.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBcQAg&amp;usg=AOvVaw1XF58pwXPRaq23YrO9KkoA">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Andy Baumert BATTELLE PLATFORM RECOMMENDATIONS Act
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.iowaregents.edu › media › cms
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           that commercialization was proposed to be through a subsidiary of a startup company in another ... company, Corixa, which was recently purchased for $300 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBgQAg" href="/url?q=https://www.genomeweb.com/archive/third-wave-adds-clinical-genetics-execs-deltagen-hires-rd-vp&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBgQAg&amp;usg=AOvVaw3zlrSkEtmNMJpWLgM8Dhfy">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Third Wave Adds Clinical Genetics Execs; Deltagen Hires R&amp;D VP
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.genomeweb.com › archive › third-wave-adds-clinical-genetics-execs-...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 5, 2002
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... company's merger with Corixa. Before that he was in research at Celltech. Deltagen also said that Peter Myers, executive vice president of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBUQAg" href="/url?q=https://www.wilmerhale.com/-/media/d3941faaf08840fa8a80bc0c1969abcf.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBUQAg&amp;usg=AOvVaw0XAM8aSsKQjfZFNtISZF0D">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] INSIDE: - WilmerHale
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.wilmerhale.com › media
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           wholly owned subsidiary; BioGentec share- holders received BioGentech shares ... Corixa. CRXA. 9.2. 9.25. 0.54. 44.76 1412. Crucell. CRXL. 4.22. 4.33. 2.61. 26.61.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBQQAg" href="/url?q=https://www.geekwire.com/2022/seattle-area-company-that-aims-to-treat-disease-with-radio-frequency-energy-files-for-ipo/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBQQAg&amp;usg=AOvVaw3qoA2MfsWF2NDepoTqqMm7">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Seattle-area company that aims to treat disease with radio frequency ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.geekwire.com › Health/Life Sciences
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 17, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           He also was head of commercial operations at Corixa and held a similar operations role at Genzyme. He previously founded Hyperion ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBMQAg" href="/url?q=https://www.govinfo.gov/content/pkg/FR-2000-11-14/pdf/00-29054.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBMQAg&amp;usg=AOvVaw36Ide7ynts7nt5gHsN6LFC">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Federal Register/Vol. 65, No. 220/Tuesday, November 14, 2000 ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.govinfo.gov › content › pkg › pdf
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 14, 2000
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Firstar Corporation's subsidiary banks are Firstar Bank, ... Corixa Corporation ............................ Corixa Corporation ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBIQAg" href="/url?q=https://ir.exelixis.com/node/7491/html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBIQAg&amp;usg=AOvVaw0qy0y6338y3DuYiVlNVjGI">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Exelixis, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.exelixis.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... owned subsidiary of Exelixis. If the merger is completed, each outstanding ... Corixa Corp; and - Calgene Inc. and Monsanto Co. These precedent ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBYQAg" href="/url?q=https://www.thepharmaletter.com/first-approval-of-melacine-in-canada&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBYQAg&amp;usg=AOvVaw1bp2r9XfRHD9RTGe33VELr">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           First approval of Melacine in Canada - The Pharma Letter
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.thepharmaletter.com › first-approval-of-melacine-in-canada
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Nov 5, 1999
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           first, approval, melacine, canada, corixa, corp, therapeutic. ... Antengene Corporation is a Chinese clinical-stage biopharmaceutical company ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBEQAg" href="/url?q=https://theorg.com/org/proniras/org-chart/steven-gillis&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBEQAg&amp;usg=AOvVaw2inY82-TUmnj-k42y1diT2">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Steven Gillis - Director at Proniras - The Org
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          theorg.com › org › proniras › org-chart › steven-gillis
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Dr. Gillis was a founder and director of Corixa Corporation and served as the company's Chief Executive Officer since inception and as its chairman since ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECA8QAg" href="/url?q=https://www.chemanager-online.com/en/news/catalent-announces-two-senior-appointments-expand-biologics-business&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECA8QAg&amp;usg=AOvVaw2qEZyPSds1boMDVofC3pLC">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Catalent Announces Two Senior Appointments to Expand Biologics ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.chemanager-online.com › news › catalent-announces-two-senior-app...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Mar 11, 2014
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... subsidiary of the company and was responsible for global transactional and strategic value creation. ... Mitcham was with Corixa Corporation where ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECA0QAg" href="/url?q=http://ir.macrogenics.com/news-releases/news-release-details/macrogenics-acquires-eliance-inc-and-establishes-partnership&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECA0QAg&amp;usg=AOvVaw2T6Pcu1sGLunWIgh0YHBav">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           MacroGenics Acquires Eliance, Inc., and Establishes Partnership in ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.macrogenics.com › news-releases › news-release-details › macrogenics-a...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 7, 2002
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Corixa, Cor Therapeutics, Coulter Pharmaceutical, Cubist ... Founded in 1997, the company's portfolio companies have raised more than ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAwQAg" href="/url?q=https://www.ziprecruiter.com/Jobs/Ehs-Pharmaceutical/--in-Pennsylvania&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAwQAg&amp;usg=AOvVaw2jL7YUiLfdb-icjyxjO29G">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           $63k-$106k Ehs Pharmaceutical Jobs in Pennsylvania - ZipRecruiter
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.ziprecruiter.com › All Jobs › Ehs Pharmaceutical Jobs
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           9627 Corixa Corporation. Senior EHS&amp;S Specialist - Chemicals &amp; Industrial ... BioLife Plasma Services is a subsidiary of Takeda Pharmaceutical Company Ltd.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBAQAg" href="/url?q=https://ir.achievelifesciences.com/sec-filings/all-sec-filings/content/0001193125-23-125216/0001193125-23-125216.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECBAQAg&amp;usg=AOvVaw0_l3c4ZVGI-sIcf-aXVoqE">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] Achieve Life Sciences, Inc.
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          ir.achievelifesciences.com › sec-filings › all-sec-filings › content
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Apr 28, 2023
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Development of Corixa Corporation. Prior to 1999, Dr. Jacobs held ... already rendered to the Company or any Parent, Subsidiary, or Affiliate.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAoQAg" href="/url?q=https://www.clearygottlieb.com/news-and-insights/news-listing/glaxosmithkline-in-dermatological-divestiture-to-altana60&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAoQAg&amp;usg=AOvVaw2dJtTW5BESTTT8EnQW3sR9">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GlaxoSmithKline in Dermatological Divestiture to ALTANA
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.clearygottlieb.com › news-and-insights › news-listing › glaxosmithkli...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Oct 6, 2005
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           PharmaDerm, a division of ALTANA Inc, will manufacture and market the former GSK products, including Aclovate®, a synthetic corticosteroid; ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAsQAg" href="/url?q=https://investors.biogen.com/static-files/f993e21a-d0be-4669-9bcb-22d6860a6dc1&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAsQAg&amp;usg=AOvVaw1rOOWkSw_BYxLGm0xAIGR8">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] united states securities and exchange commission
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.biogen.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           One suit is against Corixa Corporation, Coulter Pharmaceuticals, Inc., and ... Corporation and subsidiary as of December 31, 2001 and 2000, and the ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECA4QAg" href="/url?q=https://insights.greyb.com/gsk-subsidiaries/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECA4QAg&amp;usg=AOvVaw3-ad89qvCS9Y5SuvpXMnlx">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           GSK Company Subsidiaries - Insights;Gate
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          insights.greyb.com › Articles
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 14, 2024
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Corixa Corporation, United States. 9, Glaxosmithkline Capital Inc, United States. 10, Glaxosmithkline Llc, United States. 11, Gsk Equity ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAkQAg" href="/url?q=https://www.drugdiscoveryonline.com/doc/biovation-and-micromet-form-collaboration-to-0001&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAkQAg&amp;usg=AOvVaw2dq6xUQkNVt8h6bwaOiMXl">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Biovation And Micromet Form Collaboration To Design Novel Non ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.drugdiscoveryonline.com › doc › biovation-and-micromet-form-coll...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Aug 28, 2001
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Biovation is a wholly-owned subsidiary of Merck KGaA and operates as an independent company within the Merck group in Aberdeen, Scotland.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAUQAg" href="/url?q=https://www.zonebourse.com/insider/STEF-HEYLEN-A2XF0R/reseau/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAUQAg&amp;usg=AOvVaw3KChSEg1yijkjnHYiEDIjq">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Réseau de Stef Heylen, Analyse des 9 relations - Zonebourse
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.zonebourse.com › Insiders › Stef Heylen
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Dec 16, 2022
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAYQAg" href="/url?q=https://www.pheast.com/company/&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAYQAg&amp;usg=AOvVaw2TxMR5BgJqVcn1h5UHrcbd">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Company - Pheast Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.pheast.com › company
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Prior to Corixa, Dr. Gillis was a founder and director of Immunex Corporation. From 1981 until his departure in 1994, he served as Immunex's Director of ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAcQAg" href="/url?q=https://www.allergytherapeutics.com/media/1109/atl_admission_document_6_october_2004-3.pdf&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAcQAg&amp;usg=AOvVaw0AOJDWceBDaLPIVemD1thB">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] 64374 Atlas 2 Intro - Allergy Therapeutics
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          www.allergytherapeutics.com › media › atl_admission_document_6_...
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Oct 6, 2004
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           “Allergy Therapeutics (UK) Limited” a wholly owned subsidiary of the Company ... owned by Corixa. The licence is exclusive for the European ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad xpd EtOod pkphOe">
     <div class="kCrYT">
      <span class="cAuxJf">
       <div class="BNeawe">
        <span class="BNeawe">
         <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQsAR6BAgBEAE" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=GfaWZumpMIeKwbkPmaWj4AI&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQsAR6BAgBEAE">
          <span>
           <span class="FCUp0c rQMQod">
            Images
           </span>
          </span>
         </a>
        </span>
       </div>
      </span>
      <div class="BNeawe tAd8D AP7Wnd">
       <span class="BNeawe">
        <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ7Al6BAgBEAI" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=GfaWZumpMIeKwbkPmaWj4AI&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ7Al6BAgBEAI">
         <span class="tAd8D AP7Wnd">
          <span class="rQMQod Xb5VRe">
           View all
          </span>
         </span>
        </a>
       </span>
      </div>
     </div>
     <div>
      <div>
       <div>
        <div class="Xdlr0d">
         <div class="idg8be">
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAQ" href="https://www.google.com/imgres?imgurl=https://images.crunchbase.com/image/upload/c_pad,h_256,w_256,f_auto,q_auto:eco,dpr_1/v1407384666/jbei92nhkdjs8v1sickj.jpg&amp;imgrefurl=https://www.crunchbase.com/acquisition/glaxosmithkline-acquires-corixa-corp--d582bf80&amp;h=256&amp;w=256&amp;tbnid=Yjo0xWF9zSj7qM&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbnh=111&amp;tbnw=111&amp;usg=AI4_-kTIOl8xQjY0V-r8dJbInWhtjJIqAg&amp;vet=1&amp;docid=oo20gPBtuYde5M&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAQ">
           <div>
            <img alt="GlaxoSmithKline acquires Corixa - Crunchbase Acquisition Profile" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSHfsTlsk597IYxb7m7VMOGLEGjBM3xnjS6M6m_0Ddb1TFvnRDiyDF4cTtF_SM&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAY" href="https://www.google.com/imgres?imgurl=x-raw-image:///db8f98e8919c743c5d3e86262b48515988e1e6b42a4885576d160576d785a3f4&amp;imgrefurl=https://www.genewatch.org/uploads/f03c6d66a9b354535738483c1c3d49e4/JT_Briefing.pdf&amp;h=2264&amp;w=1600&amp;tbnid=PHSckeiYj9vGpM&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbnh=150&amp;tbnw=106&amp;usg=AI4_-kTKQTSwQeprweUefXp6AEdQaF0skg&amp;vet=1&amp;docid=kNwsQf9TcNIyHM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAY">
           <div>
            <img alt="JT Briefing" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcSfMOXKKJojyodKMxgelu67gm8xPJ5ltJMU7t9knO0vxKxFRkyhuaDsrGMIYg&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAg" href="https://www.google.com/imgres?imgurl=x-raw-image:///068aa076c3db45b829bb62dd26496e702b260598568ce7283cb0d1a6c78c6a98&amp;imgrefurl=https://link.springer.com/content/pdf/10.1007/BF03256966.pdf&amp;h=2071&amp;w=1600&amp;tbnid=uEXbw3agigaeIM&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbnh=150&amp;tbnw=116&amp;usg=AI4_-kTMUHDcvf-caxZDufNzT-dyD5JyIg&amp;vet=1&amp;docid=40Qmgnaf6MRanM&amp;itg=1&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAg">
           <div>
            <img alt="Corporate Activity – Mergers and Acquisitions" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQHXEH7ZUrgCYFj0mS_OqLprg2lRxCnJ1IHkPpYUh2ATceyaHvZaW4e8JLW&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAo" href="https://www.google.com/imgres?imgurl=https://frazierls.com/wp-content/uploads/2023/08/rempex-logo-1.png&amp;imgrefurl=https://frazierls.com/portfolio/&amp;h=325&amp;w=526&amp;tbnid=_qQFi9UP2Ev3aM&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbnh=82&amp;tbnw=132&amp;usg=AI4_-kQM841lwtFMaVlWDjCIKN0FGCDy1g&amp;vet=1&amp;docid=GiYa1gWCQm1GHM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAo">
           <div>
            <img alt="Portfolio - Frazier Life Sciences" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRryKnZp9Rg4yto25YewSfrm4dqFPYw9cgX0NBqf1388aDcyPh4jL3wt3u7aQ&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAw" href="https://www.google.com/imgres?imgurl=https://frazierls.com/wp-content/uploads/2023/08/incline-therapeutics-logo-1.png&amp;imgrefurl=https://frazierls.com/portfolio/&amp;h=325&amp;w=526&amp;tbnid=SKcfHhlwMzl88M&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbnh=82&amp;tbnw=132&amp;usg=AI4_-kS4cXbJVk8sgyv_fEnRb77XV8J7bA&amp;vet=1&amp;docid=GiYa1gWCQm1GHM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEAw">
           <div>
            <img alt="Portfolio - Frazier Life Sciences" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcRqULkRpq_Hjt0JFnn2cguDW0lUtc2QACnfbtvw7I4iGcvQzbu6tVSZ5sZy_g&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <a class="BVG0Nb OxTOff" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEA4" href="https://www.google.com/imgres?imgurl=https://frazierls.com/wp-content/uploads/2023/08/scilex-logo-1.png&amp;imgrefurl=https://frazierls.com/portfolio/&amp;h=325&amp;w=526&amp;tbnid=iRwIvdZnCrlcfM&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbnh=82&amp;tbnw=132&amp;usg=AI4_-kQYjkrUFQCVucvHRrHd-i4awc4AhQ&amp;vet=1&amp;docid=GiYa1gWCQm1GHM&amp;hl=en&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ9QF6BAgBEA4">
           <div>
            <img alt="Portfolio - Frazier Life Sciences" class="WddBJd" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcTEkoFMiuHYFWALvEuygeCaM57y1jj3xbdVSHIXJMNolOS-o5Pl0XM4VJY-L48&amp;s" style="max-width:none;height:128px;max-height:128px"/>
           </div>
          </a>
          <div class="mHhylf">
           <div class="WZ5GJf">
            <a class="qN9Ked" data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ7Al6BAgBEA8" href="https://www.google.com/search?num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=GfaWZumpMIeKwbkPmaWj4AI&amp;q=What+is+Corixa+a+subsidiary+of?&amp;tbm=isch&amp;sa=X&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ7Al6BAgBEA8">
             <button class="DXk5Me Qi9Fd" tabindex="-1">
              <span class="hWHuJ">
               <span class="Dk7jOe z1asCe lYxQe">
                <svg focusable="false" viewbox="0 0 24 24" xmlns="http://www.w3.org/2000/svg">
                 <path d="M12 4l-1.41 1.41L16.17 11H4v2h12.17l-5.58 5.59L12 20l8-8z">
                 </path>
                </svg>
               </span>
              </span>
             </button>
             <div class="BNeawe ji5jpf s3v9rd AP7Wnd">
              View all
             </div>
            </a>
           </div>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAIQAg" href="/url?q=https://investor.anipharmaceuticals.com/static-files/5c58caab-ae45-47d9-8117-36315a24e3e9&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAIQAg&amp;usg=AOvVaw2KD7skblUSQl8ENzJnegNN">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           [PDF] united states securities and exchange commission - form 10-qsb
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investor.anipharmaceuticals.com › static-files
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           <span class="r0bn4c rQMQod">
            Jun 30, 2003
           </span>
           <span class="r0bn4c rQMQod">
            ·
           </span>
           ... Corixa Corporation for use in several potential vaccines to be ... Company or any subsidiary or parent corporation of the Company ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAMQAg" href="/url?q=https://clin.larvol.com/trial/NCT00022893&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAMQAg&amp;usg=AOvVaw0dv92XbysGXAfknHYmGL3Y">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the ...
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          clin.larvol.com › trial › NCT00022893
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Corixa Corporation. N=0. Unknown status. Non-Randomized. Related Trials (6) Milestone (3). All related trials. ZEVALIN-DUI / NCT01448928. Zevalin Post-marketing ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAgQAg" href="/url?q=https://investors.dynavax.com/node/13721/html&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECAgQAg&amp;usg=AOvVaw06rLjpyU7j3QtgkFkgbMul">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           SEC Filing - Investor Relations | Dynavax Technologies Corporation
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          investors.dynavax.com › node › html
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           ... owned subsidiary which the Company refers to as Dynavax Europe. ... Corixa Corporation 1124 Columbia Street, Suite 200. Seattle, Washington 98104 ...
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <div>
    <div class="Gx5Zad fP1Qef xpd EtOod pkphOe">
     <div class="egMi0 kCrYT">
      <a data-ved="2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGIQAg" href="/url?q=https://invivo.citeline.com/companies/180&amp;sa=U&amp;ved=2ahUKEwipmszlz6yHAxUHRTABHZnSCCwQFnoECGIQAg&amp;usg=AOvVaw2V0AoZrnV33KcNANP5B347">
       <div class="DnJfK">
        <div class="j039Wc">
         <h3 class="zBAuLc l97dzf">
          <div class="BNeawe vvjwJb AP7Wnd UwRFLe" style="-webkit-line-clamp:2">
           Company Details :: In Vivo - Citeline
          </div>
         </h3>
        </div>
        <div class="sCuL3">
         <div class="BNeawe UPmit AP7Wnd lRVwie">
          invivo.citeline.com › companies
         </div>
        </div>
       </div>
      </a>
     </div>
     <div class="kCrYT">
      <div>
       <div class="BNeawe s3v9rd AP7Wnd">
        <div>
         <div>
          <div class="BNeawe s3v9rd AP7Wnd">
           Affinivax, Inc. Cellzome; Corixa Corporation; Fountain Acquisition Corporation; Genelabs Technologies, Inc. GlycoVaxyn AG; Human Genome Sciences, Inc.
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </div>
   <footer>
    <div>
     <div class="Gx5Zad xpd EtOod pkphOe BmP5tf">
      <div class="nMymef Va3FIb lVm3ye">
       <a aria-label="Next page" class="nBDE1b G5eFlf" href="/search?q=What+is+Corixa+a+subsidiary+of%3F&amp;num=100&amp;lr=lang_en&amp;sca_esv=1a233ca9bb5af21c&amp;hl=en&amp;gbv=1&amp;gl=us&amp;tbs=lr:lang_1en&amp;ei=GfaWZumpMIeKwbkPmaWj4AI&amp;start=100&amp;sa=N">
        Next &gt;
       </a>
      </div>
     </div>
    </div>
    <div id="EOlPnc">
     <div class="Srfpq">
      <div>
       <span class="EYqSq unknown_loc">
       </span>
       <span class="dfB0uf">
        Georgia
       </span>
      </div>
      <span>
       From your IP address
      </span>
      <span>
       -
      </span>
      <a aria-label="Learn more about this location" class="IffyKc" href="/url?q=https://support.google.com/websearch%3Fp%3Dws_settings_location%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQty4I4gM&amp;usg=AOvVaw1prNTZb0vYRLOzBj3qpoi5" tabindex="0">
       Learn more
      </a>
     </div>
     <div>
      <a href="/url?q=https://accounts.google.com/ServiceLogin%3Fcontinue%3Dhttps://www.google.com/search%253Fhl%253Den%2526source%253Dhp%2526q%253DWhat%252Bis%252BCorixa%252Ba%252Bsubsidiary%252Bof%25253F%2526btnG%253DGoogle%252BSearch%2526iflsig%253DAL9hbdgAAAAAZpcEKXXIBTyPFuMGAByodjXr-VnscjVY%2526gbv%253D1%2526lr%253Dlang_en%2526gl%253Dus%2526num%253D100%26hl%3Den&amp;opi=89978449&amp;sa=U&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQxs8CCOMD&amp;usg=AOvVaw1Jp2-WC3holDohqEHchr3w">
       Sign in
      </a>
     </div>
     <div>
      <a class="xeDNfc" href="https://www.google.com/preferences?hl=en&amp;fg=1&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQ5fUCCOQD">
       Settings
      </a>
      <a class="xeDNfc" href="https://policies.google.com/privacy?hl=en&amp;fg=1">
       Privacy
      </a>
      <a class="xeDNfc" href="https://policies.google.com/terms?hl=en&amp;fg=1">
       Terms
      </a>
      <a class="xeDNfc" href="/setprefs?hl=en&amp;prev=https://www.google.com/search?hl%3Den%26source%3Dhp%26q%3DWhat%2Bis%2BCorixa%2Ba%2Bsubsidiary%2Bof?%26btnG%3DGoogle%2BSearch%26iflsig%3DAL9hbdgAAAAAZpcEKXXIBTyPFuMGAByodjXr-VnscjVY%26gbv%3D1%26lr%3Dlang_en%26gl%3Dus%26num%3D100%26pccc%3D1&amp;sig=0_z5xLmps5rR6VzKYqNGbKj8MBSJ0%3D&amp;cs=2&amp;sa=X&amp;ved=0ahUKEwipmszlz6yHAxUHRTABHZnSCCwQjcAJCOUD">
       Dark theme: Off
      </a>
     </div>
    </div>
   </footer>
  </div>
  <!-- cctlcm 5 cctlcm -->
  <textarea class="csi" name="csi" style="display:none"></textarea>
 </body>
</html>
